How strong is your Drug Discount Management strategy?
Too often, drug manufacturers find themselves losing a notable percentage of their revenue because of noncompliant discounts. While some organizations might identify up to 10% of their transactions as duplicate discounts, even a 3-5% rate of noncompliance can have significant impact when you have an industry where rebates and discounts added up to a total of $187 billion in 2020.
The best defense for organizations is to have a robust and effective strategy for managing their drug discounts and disputes. How does your current approach hold up?
Take our quiz to find out.